Director, Strategic Development

Director, Strategic Development

We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.

United Therapeutics (Nasdaq : UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).

The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.

The Director, Strategic Development will support development and execution of clinical development strategy for all assigned programs from inception (Phase 1-3) to successful product approval by the FDA and other regulatory agencies.

• Design and review clinical protocols, data analysis plans, interpretation of results, clinical study reports, and supporting work for sections of regulatory submissions, such as, INDs, CTAs, NDAs, MAAs and regulatory agency briefing packages, etc.
• Prepare, present, and defend complex aspects of protocol design and / or study data at investigator and internal meetings
• Prepare and review draft abstracts and manuscripts for publication in consultation with other team members / collaborators
• Assist in researching and drafting of sections or entire documents, as assigned, such as DSURs, other study reports and documents, investigator brochures, etc.
• Critically analyze and synthesize complex information from reviews of the scientific / clinical literature
• Collaborate with Medical Science Liaisons and other company staff in identifying key partners for future research studies / projects
• Manage and support Clinical Operations resources in evaluating, selecting, and engaging research-oriented investigative sites for company-sponsored studies and future research projects
• Attend appropriate external scientific events to maintain awareness of research activities and represent a project and / or the company
• Participate in cross-functional teams, departmental meetings, and regulatory meetings
• Offer scientific insights into therapeutic areas and disease specific information as required

For this role you will need :

Preferred Qualifications :

Job Location :

This hybrid role is located in Durham, NC, and requires at least four in-office days a week. Expected travel for this role is up to 25%.

At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.

Eligible employees may participate in the Company's comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more.

United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.